Skip to Navigation | Skip to Main Content | Skip to Site Map

MyFloridaHouse.gov | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

CS/CS/HB 883 — Short-acting Bronchodilator Use in Public and Private Schools

by Health & Human Services Committee; Choice & Innovation Subcommittee; and Rep. Koster and others (CS/CS/SB 962 by Rules Committee; Health Policy Committee; and Senator Hooper)

This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.

Prepared by: Education Pre-K -12 Committee (ED)

The bill provides a framework for public and private schools to treat students with asthma or who are otherwise in respiratory distress. The bill authorizes:

  • Trained staff to administer short-acting bronchodilators to students in respiratory distress and includes civil immunity for good-faith administration.
  • Schools to acquire and safely maintain a supply of bronchodilators.
  • Allopathic and osteopathic physicians, physician assistants, and advanced practice registered nurses to prescribe bronchodilators and components issued in the name of a public or private school.
  • Licensed pharmacists to dispense bronchodilators and components pursuant to a prescription issued in the name of a public or private school, and includes civil and criminal immunity for a healthcare practitioner or pharmacist that dispenses short-acting bronchodilators or components in good faith and with reasonable care.

If approved by the Governor, or allowed to become law without the Governor’s signature, these provisions take effect July 1, 2024.

Vote: Senate 34-0; House 115-0